MRNA - Buy after a sell-off, Vaccines are here to stay

21 sty 2022

Vaccines are here to stay and many companies will have a good balance sheet in coming years. Moderna is a buy and I am DCAing from 186 down to every monthly dip.

MRNA will recover above 200 within 2022

7 lut 2022

Uwaga

MRNA is simply bottoming, should be 200+ in a few months.

26 maj 2022

Uwaga

Still waiting and expecting a decent rebound above 200.

6 sie 2022

Uwaga

Good earnings, and a solid cash flow in MRNA...Ignoring the FUD.

Still MRNA is in business. Looking forward to 200+ finally.

14 sie 2022

Uwaga

Pure sideways market - it is here to stay. I loaded more MRNA around 172.x. Can it deliver 225 this year? That should what we ask, instead SIG *Stay-in the Game*